A subset of DLBCL cases showed characteristics of plasmacytic differentiation (13/51; 25.5%), in which a fraction of tumor cells lost the B cell marker (B220) and expressed the plasma cell marker (CD138) (Supplementary Figure 3). Here, SDC1 is linked to diffuse large B-cell lymphoma.